Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 19 Breast Neoplasms 15 Prostatic Neoplasms 14 Colorectal Neoplasms 14 Hematopoietic and Lymphatic System Neoplasm 12 Lung Neoplasms 10 Ovarian Neoplasms 5 Multiple Myeloma 5 Hematologic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Malignant Solid Neoplasm 4 Hematopoietic and Lymphoid System Neoplasm 4 Depression 4 Uterine Cervical Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Malignant Solid Neoplasm 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Cancer, Papillary 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Motor Activity 2 Melanoma 2 Malignant Female Reproductive System Neoplasm 2 Leukemia 2

Interventions

Doxorubicin 18 Ifosfamide 13 Radiotherapy 8 Paclitaxel 7 pazopanib 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Etoposide 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 trebananib 2 regorafenib 2 cixutumumab 2 cemiplimab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangiosarcoma × Interviews as Topic × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡